Search results
21 lip 2022 · Stanford Infectious Diseases' Dr. Anne Liu explains why people are reporting getting hives after recovering from COVID-19.
1 mar 2022 · The authors provide an update on the diagnostic and prognostic value of the 5 most common cutaneous abnormalities associated with COVID-19 in adult patients: morbilliform rash, urticaria, vesicles, pseudo-chilblains, and vaso-occlusive lesions. KEY POINTS.
15 sty 2021 · Papulosquamous eruptions lasted 20 days (IQR 14–28) in laboratory-confirmed cases, with one case having a confirmed long-hauler eruption lasting 70 days. Pernio lasted a median of 15 days (IQR 10–30) in patients with suspected COVID-19, and 12 days (IQR 7–23) in laboratory-confirmed cases.
Management of urticarial in COVID-19 patients should involve antihistamines. Low dose prednisolone should be considered on an individualized basis. Further research is required in understanding urticarial pathogenesis in COVID-19.
28 wrz 2020 · Management of urticarial in COVID-19 patients should involve antihistamines. Low dose prednisolone should be considered on an individualized basis. Further research is required in understanding urticarial pathogenesis in COVID-19.
12 cze 2023 · COVID-19 can cause hives during the day or night. Learn more about hives that develop only at night, including other possible causes, like allergies.
7 wrz 2021 · Raised erythematous plaques (wheals) on the palm, arm and leg of a 27-year-old woman with SARS-CoV-2 infection. The most likely diagnosis was chronic spontaneous urticaria triggered by SARS-CoV-2, but other considerations were urticarial vasculitis and chronic inducible urticaria.
